JPH0341085A - Novel sugar alcohol, its production and use - Google Patents
Novel sugar alcohol, its production and useInfo
- Publication number
- JPH0341085A JPH0341085A JP1191296A JP19129689A JPH0341085A JP H0341085 A JPH0341085 A JP H0341085A JP 1191296 A JP1191296 A JP 1191296A JP 19129689 A JP19129689 A JP 19129689A JP H0341085 A JPH0341085 A JP H0341085A
- Authority
- JP
- Japan
- Prior art keywords
- sugar alcohol
- gal
- residue
- sorbitol
- galactopyranosyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000005846 sugar alcohols Chemical class 0.000 title claims description 64
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 26
- 239000008101 lactose Substances 0.000 claims abstract description 26
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 17
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 17
- 206010010774 Constipation Diseases 0.000 claims abstract description 13
- 229960002920 sorbitol Drugs 0.000 claims abstract description 12
- 102000005936 beta-Galactosidase Human genes 0.000 claims abstract description 11
- 108010005774 beta-Galactosidase Proteins 0.000 claims abstract description 11
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 10
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims abstract description 10
- 102000006995 beta-Glucosidase Human genes 0.000 claims abstract description 9
- 108010047754 beta-Glucosidase Proteins 0.000 claims abstract description 9
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 241000186000 Bifidobacterium Species 0.000 claims description 20
- 239000000832 lactitol Substances 0.000 claims description 19
- 229960003451 lactitol Drugs 0.000 claims description 19
- 235000010448 lactitol Nutrition 0.000 claims description 18
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 7
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 6
- 239000012279 sodium borohydride Substances 0.000 claims description 6
- 238000006276 transfer reaction Methods 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 239000000463 material Substances 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000006462 rearrangement reaction Methods 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 210000003608 fece Anatomy 0.000 description 10
- 239000000843 powder Substances 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 230000013872 defecation Effects 0.000 description 7
- 239000000600 sorbitol Substances 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- 229930182830 galactose Natural products 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000003463 adsorbent Substances 0.000 description 4
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 4
- 150000003271 galactooligosaccharides Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 235000008476 powdered milk Nutrition 0.000 description 3
- 230000002062 proliferating effect Effects 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 241001608472 Bifidobacterium longum Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000002464 Galactosidases Human genes 0.000 description 2
- 108010093031 Galactosidases Proteins 0.000 description 2
- 102000004366 Glucosidases Human genes 0.000 description 2
- 108010056771 Glucosidases Proteins 0.000 description 2
- 241000282567 Macaca fascicularis Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- -1 Raney nickel Chemical compound 0.000 description 2
- 229940009291 bifidobacterium longum Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000020124 milk-based beverage Nutrition 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- MYKOKMFESWKQRX-UHFFFAOYSA-N 10h-anthracen-9-one;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 MYKOKMFESWKQRX-UHFFFAOYSA-N 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001655328 Bifidobacteriales Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003048 aphrodisiac agent Substances 0.000 description 1
- 230000002509 aphrodisiac effect Effects 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 210000000110 microvilli Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
庄−朶よ14貝止走竪
本発明は、新規な糖アルコール及びそれを製造するため
の方法、さらにはその利用に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel sugar alcohol, a method for producing the same, and further its use.
この糖アルコールは生体内のビフィズス菌に対して優れ
た増殖作用を有し、また、食物繊維、乳糖並びにラクチ
トールと併用して摂取した場合、顕著な便秘改善作用を
示すことから、これらの作用を利用した生理活性剤とし
ての有用性が期待される。This sugar alcohol has an excellent proliferative effect on Bifidobacterium in the body, and when taken in combination with dietary fiber, lactose, and lactitol, it shows a remarkable effect on improving constipation. It is expected to be useful as a bioactive agent.
技111i量
従来、ビフィズス菌の増殖を促進する物質(以下ビフィ
ズス菌増殖因子と称する)について多くの研究がなされ
ており、その増殖因子としてオリゴ糖が注目されている
。そして、このようなオリゴ糖として、乳糖又は乳糖含
有物に、アスペルギルス・オリゼの生産したβ−ガラク
トシダーゼを作用させることで得られる、−形式
%式%
(ただし、式中Gal はガラクトース残基を、Glc
はグルコース残基を示し、nは1〜4の整数を示す)で
表わされるオリゴ糖をビフィズス菌増殖因子として用い
ることが提案されている 〔特開昭55104885号
)。Many studies have been conducted on substances that promote the growth of bifidobacteria (hereinafter referred to as bifidobacterial growth factors), and oligosaccharides have attracted attention as growth factors. Such an oligosaccharide is obtained by reacting β-galactosidase produced by Aspergillus oryzae with lactose or a lactose-containing substance, in the form % formula % (where Gal represents a galactose residue, Glc
indicates a glucose residue, and n indicates an integer from 1 to 4) has been proposed to be used as a Bifidobacterium growth factor [JP-A-55104885].
本発明者は、乳糖又は乳糖含有物にβ−ガラクトシダー
ゼあるいはβ−グルコシダーゼを作用させて得られるオ
リゴ糖中のグルコース残基を還元することにより、及び
ラクチトール又はラクチトール含有物にβ−ガラクトシ
ダーゼ或はβ−グルコシダーゼを作用させることにより
、新規な糖アルコールが得られること、そしてこの糖ア
ルコールがビフィズス菌の増殖作用及び乳糖や食物繊維
との併用摂取により顕著な便秘改善作用を有することの
知見を得て本発明をなすに至った。The present inventor has demonstrated that by reducing glucose residues in oligosaccharides obtained by treating lactose or lactose-containing substances with β-galactosidase or β-glucosidase, and by treating lactitol or lactitol-containing substances with β-galactosidase or β-glucosidase. - Obtained the knowledge that a new sugar alcohol can be obtained by the action of glucosidase, and that this sugar alcohol has a proliferating effect on bifidobacteria and a remarkable effect on improving constipation when taken in combination with lactose and dietary fiber. The present invention has been accomplished.
しよ゛と る
したがって、本発明は、如上の生理的作用を示す新規糖
アルコール及び該糖アルコールを製造するための方法、
更には、この糖アルコールを活性成分として含有するビ
フィズス菌増殖促進組成物と便秘改善性組成物を提供す
ることを課題とする。Therefore, the present invention provides a novel sugar alcohol exhibiting the above-mentioned physiological effects, a method for producing the sugar alcohol,
Furthermore, it is an object of the present invention to provide a bifidobacteria growth-promoting composition and a constipation-improving composition containing this sugar alcohol as an active ingredient.
課題上邂決i?)?、:に勘1L段
本発明に係る糖アルコールは下記一般式(I)%式%
()
(ただし、式中Gal はガラクトース残基を、Sor
はソルビト−ル残基をそれぞれ示し、nは1〜4の整数
を示す)
上記一般式(I)で表わされる糖アルコールは下記式(
1)〜(3)で表わされる各糖アルコールを包含する。Did you decide on the assignment? )? The sugar alcohol according to the present invention has the following general formula (I)% formula% () (However, in the formula, Gal represents a galactose residue, Sor
each represents a sorbitol residue, and n represents an integer of 1 to 4.) The sugar alcohol represented by the above general formula (I) is represented by the following formula (
It includes each sugar alcohol represented by 1) to (3).
式(+)
0−β−D−ガラクトピラノシル−(1→6)−〇−β
−D−ガラクトピラノシル−(1→4)−〇−ソルビト
ール (1)式(2)
0−β−D−ガラクトピラノシル−(1→3)−〇−β
−D−ガラクトピラノシル−〈1→4)−〇−ソルビト
ール (2)式(3)
0−β−D−ガラクトピラノシル−(1→4)−[0−
β−D−ガラクトピラノシル−(1→6) )−D−ソ
ルビトール (3)これらの糖アルコールの物性及び
構成糖と糖アルコールを示すと次のとおりである。Formula (+) 0-β-D-galactopyranosyl-(1→6)-〇-β
-D-galactopyranosyl-(1→4)-〇-sorbitol (1) Formula (2) 0-β-D-galactopyranosyl-(1→3)-〇-β
-D-galactopyranosyl-<1→4)-〇-sorbitol (2) Formula (3) 0-β-D-galactopyranosyl-(1→4)-[0-
β-D-galactopyranosyl-(1→6))-D-sorbitol (3) The physical properties and constituent sugars and sugar alcohols of these sugar alcohols are as follows.
(イ)分子量 質量分析計による測定では分子量506を有する。(a) Molecular weight It has a molecular weight of 506 as measured by a mass spectrometer.
(ロ)色調
乾燥、粉末化したものはいずれも白色を呈する(ハ)酸
性、塩基性及び中性の区別
いずれも中性を示す。(b) Color When dried and powdered, all exhibit a white color. (c) Distinction between acidic, basic and neutral, all indicate neutrality.
(ニ)溶解性
いずれも水に可溶性であるが、ベンゼン、クロロホルム
、アセトンに′H溶である。(d) Solubility All of them are soluble in water, but they are soluble in benzene, chloroform, and acetone.
(ホ)呈色反応
硝酸銀反応
アンスロン硫酸反応 十
ニンヒドリン反応
ビユレット反応
(へ) tR構成糖び糖アルコール
本発明に係る糖アルコールを0.5N−11CIにより
too’cの温度で4時間加水分解して得られる生成糖
及び糖アルコールのモル比はガラクトース:ソルビトー
ル=2:1であることから、本発明に係る糖アルコール
は2分子のガラクトスと1分子のソルビトールから成る
ことが確認された。(e) Color reaction Silver nitrate reaction Anthrone sulfuric acid reaction Juninhydrin reaction Biulet reaction (f) tR constituent sugar sugar alcohol The sugar alcohol according to the present invention was hydrolyzed with 0.5N-11CI at a temperature of too'c for 4 hours. Since the molar ratio of the resulting sugar and sugar alcohol was galactose:sorbitol=2:1, it was confirmed that the sugar alcohol according to the present invention consisted of two molecules of galactose and one molecule of sorbitol.
(ト)構成糖及び糖アルコールの結合態様本発明に係る
糖アルコールをそれぞれ高速液体クロマトグラフィー(
HPLC)により分離精製した後、常法によりメチル化
分析した結果表1に示す結合態様が確認された。(g) Bonding mode of constituent sugars and sugar alcohols The sugar alcohols according to the present invention were each subjected to high performance liquid chromatography (
After separation and purification by HPLC), methylation analysis was performed using a conventional method, and the binding mode shown in Table 1 was confirmed.
表
(チ)本発明の糖アルコールはβ−ガラクトシダーゼの
作用により、ガラクトースとソルビトールが生成するこ
とからβ−配位であることが確認された。Table (H) The sugar alcohol of the present invention was confirmed to be β-coordinated since galactose and sorbitol were produced by the action of β-galactosidase.
上述(イ)及び(へ〉〜(チ)に示した性質に鑑み、本
発明に係る糖アルコールは前記式(1)〜(3)でそれ
ぞれ表わされるものであると同定し得る。In view of the properties shown in (a) and (f) to (h) above, the sugar alcohols according to the present invention can be identified as those represented by the above formulas (1) to (3), respectively.
次に、本発明に係る糖アルコールの製造方法について説
明する。Next, the method for producing sugar alcohol according to the present invention will be explained.
本発明による糖アルコールは、乳糖又は乳糖含有物にβ
−ガラク1−シダーゼあるいはβ−グルコシダーゼを作
用させて乳糖分子中のガラクトース残基に転移反応を行
わせることによりオリゴ糖を生成し、得られたオリゴ糖
のグルコース残基を還元することにより得られる。また
、この糖アルコールはラクチトール又はラクチトール含
有物にβ−ガラクトシダーゼ或はβ−グルコシダーゼを
作用させることによっても得られる。The sugar alcohol according to the invention has β
- Obtained by reacting galactose residues in lactose molecules with galac-1-sidase or β-glucosidase to generate oligosaccharides, and reducing the glucose residues of the resulting oligosaccharides. . Moreover, this sugar alcohol can also be obtained by allowing β-galactosidase or β-glucosidase to act on lactitol or a lactitol-containing substance.
ここで用いるガラクトシダーゼ又はグルコシダーゼはそ
の起源を特に限定する必要がなく、また、高度に精製さ
れたものでなくてもよく、粗酵素の状態でも使用し得る
。The origin of galactosidase or glucosidase used here does not need to be particularly limited, and it does not need to be highly purified, and can be used in the form of a crude enzyme.
出発物質である乳糖又は乳糖含有物に上記酵素を作用さ
せるには、該出発物質の乳糖濃度を5〜50%に調整し
たものを基質とし、これにpif2〜8で酵素濃度0.
1〜280単位/TR1においてlO〜60’Cの温度
下に酵素を作用させるのが適当である。In order to cause the above enzyme to act on the starting material lactose or a lactose-containing substance, use the starting material whose lactose concentration has been adjusted to 5 to 50% as a substrate, and add the enzyme concentration to 0.5% with pif 2 to 8.
It is appropriate to allow the enzyme to act at a temperature of 10 to 60'C at a concentration of 1 to 280 units/TR1.
上記酵素反応により出発物質にガラクトース転移反応が
起こってオリゴ糖混合物が生成する。The enzymatic reaction causes a galactose transfer reaction to occur in the starting material, producing an oligosaccharide mixture.
次いで、オリゴ糖混合物を含有する反応液を90’以上
の温度で30秒〜3分間加熱して酵素を失活させた後、
活性炭を含む吸着剤と接触させて(通常は、該吸着剤を
充填したカラムに通す)、該反応液中のオリゴ糖を吸着
させる。Next, the reaction solution containing the oligosaccharide mixture is heated at a temperature of 90' or higher for 30 seconds to 3 minutes to inactivate the enzyme, and then
The oligosaccharide in the reaction solution is adsorbed by contacting with an adsorbent containing activated carbon (usually passed through a column packed with the adsorbent).
次に、15〜50%濃度のエタノール溶液を用いて吸着
したオリゴ糖を溶出してオリゴ糖を含む溶出液を得る。Next, the adsorbed oligosaccharides are eluted using a 15-50% ethanol solution to obtain an eluate containing oligosaccharides.
得られた該溶出液は減圧濃縮し、必要に応しさらに乾燥
する。The obtained eluate is concentrated under reduced pressure and further dried if necessary.
このようにして得られたガラクトオリゴ塘に、水溶液又
はアルコール液中で水素化ホウ素ナトリウムを作用させ
てそのグルコース残基を還元し、ソルビトールに変換す
る。この際、ガラクトオリゴ塘の濃度は1〜50%(W
/V)に、還元反応に用いる水素化ホウ素ナトリウムの
濃度を0.1〜5Mにそれぞれ調整することが好ましい
。また、上記還元反応は0〜50°Cの温度で30分〜
3時間行うことが適当である。The thus obtained galacto-oligo mass is treated with sodium borohydride in an aqueous or alcoholic solution to reduce its glucose residue and convert it into sorbitol. At this time, the concentration of galacto-oligo is 1 to 50% (W
/V), it is preferable to adjust the concentration of sodium borohydride used in the reduction reaction to 0.1 to 5M. In addition, the above reduction reaction is carried out at a temperature of 0 to 50°C for 30 minutes to
It is appropriate to do this for 3 hours.
反応終了後、反応液中の過剰な水素化ホウ素ナトリウム
を酢酸もしくはアセトン等で分解した後、該反応液を脱
塩用樹脂、電気透析、限外濾過等で脱塩処理し、得られ
た槽アルコールは減圧濃縮し、必要に応じ、凍結乾燥等
により乾燥して粉末状の目的糖アルコールを得る。After the reaction is completed, excess sodium borohydride in the reaction solution is decomposed with acetic acid or acetone, etc., and then the reaction solution is desalted using a desalting resin, electrodialysis, ultrafiltration, etc., and the resulting tank is The alcohol is concentrated under reduced pressure and, if necessary, dried by freeze-drying or the like to obtain a powdered target sugar alcohol.
また、本発明では下記方法によってもオリゴ糖のグルコ
ース残基を還元して目的糖アルコールを製造することが
できる。Furthermore, in the present invention, the target sugar alcohol can also be produced by reducing glucose residues of oligosaccharides by the following method.
上記の製造過程で得られたオリゴ糖含有溶出液を減圧′
a縮したものを高温高圧下においてラネニッケルに代表
されるニッケル触媒そ用い、水素と反応させることによ
りグルコース残基を還元してソルビトールに変換する。The oligosaccharide-containing eluate obtained in the above manufacturing process was heated under reduced pressure.
The a-condensed product is reacted with hydrogen at high temperature and high pressure using a nickel catalyst such as Raney nickel, thereby reducing glucose residues and converting them into sorbitol.
この際、ガラクトオリゴ糖の濃度は40〜70%(n/
v)に、触媒に用いるニッケル量を0.02〜5%(w
/v)にそれぞれ調整することが好ましい。また、上記
還元反応は100〜200”C(7)温度で水素圧を5
0〜17oatImニオイテ20〜5時間行うことが適
当である。At this time, the concentration of galactooligosaccharide is 40-70% (n/
v), the amount of nickel used in the catalyst is 0.02 to 5% (w
/v). In addition, the above reduction reaction is carried out at a temperature of 100 to 200"C (7) and a hydrogen pressure of 5
It is appropriate to carry out the treatment for 20 to 5 hours at 0 to 17 hours.
反応終了後、反応液中の不純物を活性炭、イオン交換樹
脂等に通液することにより除去できる。After the reaction is completed, impurities in the reaction solution can be removed by passing the solution through activated carbon, ion exchange resin, or the like.
得られた媚アルコールは減圧濃縮し、必要に応じ凍結乾
燥などにより乾燥して粉末状の目的糖アルコールを得る
。The obtained aphrodisiac alcohol is concentrated under reduced pressure and, if necessary, dried by freeze-drying or the like to obtain a powdered target sugar alcohol.
さらに、本発明では下記方法によっても目的糖アルコー
ルを製造することができる。Furthermore, in the present invention, the target sugar alcohol can also be produced by the following method.
ラクチトール又はラクチトール含有物を出発物質として
用い、これにβ−ガラクトシダーゼ或はβ−グルコシダ
ーゼを作用させてラクチトールのガラクトース残基に転
移反応を行わせることにより目的糖アルコール(ガラク
トシルラクチトール)が得られる。The target sugar alcohol (galactosyl lactitol) is obtained by using lactitol or a lactitol-containing material as a starting material and allowing β-galactosidase or β-glucosidase to act on it to cause a transfer reaction to the galactose residues of lactitol.
ここで用いるβ−ガラクトシダーゼ又はβ−グルコシダ
ーゼは、前述した乳糖又はその含有物を出発物質として
用いる場合と同様に、その起源を特に限定する必要がな
く、また、高度に精製された必要もなく、粗酵素の状態
でも良い。β-galactosidase or β-glucosidase used here does not need to be particularly limited in its origin, and does not need to be highly purified, as in the case where lactose or its containing substance is used as a starting material, as described above. The crude enzyme may also be used.
出発物質であるラクチトール又はβ−ラクチトール含有
物質に上記酵素を作用させるには該出発物質のラクチト
ール濃度5〜75%に調整したものを基質とし、これに
all 2〜8で酵素濃度0.1〜280単位/R1に
おいて】0〜60℃の温度下に酵素を作用させるのが適
当である。To cause the above enzyme to act on the starting material lactitol or β-lactitol-containing substance, use the starting material adjusted to a lactitol concentration of 5 to 75% as a substrate, and add all 2 to 8 to an enzyme concentration of 0.1 to 75%. 280 units/R1] It is appropriate to allow the enzyme to act at a temperature of 0 to 60°C.
上記酵素を作用させることにより、ラクチトールにガラ
クトース転移反応が起って目的塘アルコール混合物が生
成するので、該糖アルコールを含有する反応混合液を9
0°C以上の温度で30秒〜3分間加熱して酵素を失活
させた後、活性炭を含む吸着剤と接触させて(通常は、
該吸着剤を充填カラムに通す)該反応混合液中の糖アル
コールを吸着させる。By allowing the above enzyme to act, a galactose transfer reaction occurs on lactitol and a target alcohol mixture is produced, so the reaction mixture containing the sugar alcohol is
After inactivating the enzyme by heating at a temperature of 0°C or higher for 30 seconds to 3 minutes, the enzyme is brought into contact with an adsorbent containing activated carbon (usually,
The adsorbent is passed through a packed column to adsorb the sugar alcohol in the reaction mixture.
次に、15〜50%濃度のエタノール溶液を用いて吸着
した目的アルコールを溶出し、得られた溶出液を減圧濃
縮し、必要に応じ、凍結乾燥等により乾燥して粉末状の
目的糖アルコールを得る。Next, the adsorbed target alcohol is eluted using an ethanol solution with a concentration of 15 to 50%, the obtained eluate is concentrated under reduced pressure, and if necessary, dried by freeze-drying etc. to obtain a powdered target sugar alcohol. obtain.
上述のようにして得られる糖アルコールは、既に言及し
たごとく、生体内のビフィズス菌に対して優れた増殖作
用を有し、また食物繊維や乳糖等と併用して摂取すると
顕著な便秘改善作用を示すので、ビフィズス菌増殖促進
剤及び便秘改善剤の有効成分として利用することが可能
である。As mentioned above, the sugar alcohol obtained as above has an excellent proliferative effect on Bifidobacterium in the living body, and also has a remarkable constipation-improving effect when taken in combination with dietary fiber, lactose, etc. Therefore, it can be used as an active ingredient of a bifidobacteria growth promoter and a constipation improving agent.
次に、本発明に係る糖アルコールのビフィズス菌に対す
る増殖促進効果及び便秘改善効果を試験した結果を示す
。Next, the results of testing the growth promoting effect on bifidobacteria and the constipation improving effect of the sugar alcohol according to the present invention will be shown.
■ビフィズス菌に対する増殖試験
試験方法:
10匹を1群とするカニクイサルを供試動物として用い
、その各々に乳糖を5重量%添加した市販育児用粉乳を
5週間与えた後、本発明による糖アルコール(粉末形態
)を5重量%添加した育児用粉乳を更に3週間与え、そ
の間各サルの糞便を採取して便中のビフィズス菌の割合
を測定した。結果は添付の図面に示すとおりである。■Proliferation test test method for Bifidobacterium: Cynomolgus monkeys (groups of 10 animals) were used as test animals, and after 5 weeks of feeding commercially available powdered milk for infants with 5% by weight of lactose added to each group, sugar alcohol according to the present invention was added to each group of cynomolgus monkeys. Powdered milk for infants containing 5% by weight of (powdered form) was given for an additional 3 weeks, during which time the feces of each monkey was collected and the proportion of bifidobacteria in the feces was measured. The results are shown in the attached drawings.
図にみられるとおり、乳糖を添加して、与えた期間中の
糞便中のビフィズス菌の割合に比べ、本発明による糖ア
ルコールを添加して与えた期間中の糞便中のビフィズス
菌の割合は著しく上昇している。As seen in the figure, the proportion of bifidobacteria in feces during the period when the sugar alcohol of the present invention was added and fed was significantly higher than that during the period when lactose was added and fed. It is rising.
すなわち、本発明による塘アルコールは生体内における
ビフィズス菌の増殖促進に極めて優れた効果を奏するも
のであり、また、人間の腸管内に生育する種々のビフィ
ズス菌、例えばビフィドバクテリウム・ロンガム、ビフ
ィドバクテリウム・ブリード、ビフィドバクテリウム・
ビフィダム、ビフィドバクテリウム・アドレスセンチイ
ス、ビフィドバクテリウム・インファンテイス等の広範
囲な種類のビフィズス菌に対して高い増殖活性を示すこ
とが認められる。In other words, the Tang alcohol according to the present invention has an extremely excellent effect on promoting the growth of Bifidobacteria in vivo, and is also effective against various Bifidobacteria that grow in the human intestinal tract, such as Bifidobacterium longum and Bifidobacterium longum. Fydobacterium breed, Bifidobacterium
It is recognized that it exhibits high growth activity against a wide range of types of bifidobacteria, such as Bifidum, Bifidobacterium adressentis, and Bifidobacterium infantis.
したがって、本発明による糖アルコールは粉乳、発酵乳
のごとき乳製品に配合したり、また、整腸剤のごとき薬
剤の成分として添加して用いることができる。Therefore, the sugar alcohol according to the present invention can be blended into dairy products such as powdered milk and fermented milk, or added as a component of drugs such as intestinal preparations.
因に、本発明による糖アルコールを2重量%添加した乳
飲料を調製し、これを健康成人30名に投与したところ
、これらの糞便中の全菌数に占めるビフィズス菌の比率
の増加は、乳糖を2重量%を添加した乳飲料を同様に投
与した場合に比較して約2倍であることが認められた。Incidentally, when a milk drink containing 2% by weight of sugar alcohol according to the present invention was prepared and administered to 30 healthy adults, the increase in the ratio of bifidobacteria to the total number of bacteria in their feces was due to lactose. It was observed that the amount was approximately twice as high as when a milk drink containing 2% by weight was similarly administered.
■便秘改善試験
試験方法:
上記により得た糖アルコール粉末を、日常的に便秘ぎみ
を訴える健康な老人20名を4名づつ5のグループに分
け、試験区Nal乃至Na5として、下記配合の糖アル
コールをそれぞれ経口投与した。■Constipation improvement test test method: The sugar alcohol powder obtained above was divided into 5 groups of 4 people each to 20 healthy elderly people who complain of constipation on a daily basis, and sugar alcohol powder with the following combination was used as test groups Nal to Na5. were administered orally.
抜板k 糖アルコール投与量(g)kl
5
Na2 4
弘 33
弘 42
阻 50
各試験区ともに、上記量の糖アルコールをそれぞれ、1
日1回の割合で2週間投与して、投与前の2i!1間を
投与中の2週間における排便回数を各排便毎の糞便の硬
さを官能的に評価した。結果は表2に示すとおりである
。Cutting plate k Sugar alcohol dosage (g) kl
5 Na2 4 Hiroshi 33 Hiroshi 42 Hyo 50 In each test group, the above amount of sugar alcohol was added to 1
Administer once a day for 2 weeks, 2i before administration! The number of defecations during the two-week period during which the rats were administered was sensory evaluated for the hardness of the feces at each defecation. The results are shown in Table 2.
表 2 注) 排便回数は1人当りの2週間の平均を示す。table 2 note) The number of defecation times is the average for 2 weeks per person.
糞便の硬さは1人当りの排便毎の平均で示し、の数字は
下記5段階で示す。The hardness of feces is expressed as the average of each defecation per person, and is expressed in the following 5 levels.
非常に軟らかい 5点
軟らかい 4点
普通 3点
硬い 2点
非常に硬い 1点
表中
表にみられるとおり、本発明による糖アルコールを投与
したグループはでは3g以上の投与において排便回数の
顕著な増加と糞便の軟化が認められた。囚に、対照区で
は排便回数の増加及び糞便の軟化はほとんど認められな
かった。Very soft 5 points Soft 4 points Average 3 points Hard 2 points Very hard 1 point As shown in the table, the group administered the sugar alcohol of the present invention showed a significant increase in the frequency of defecation when 3 g or more was administered. Softening of feces was observed. In the control group, no increase in the frequency of defecation or softening of feces was observed in the prisoners.
上述したとおり、本発明による糖アルコールの単独投与
により顕著な便秘改善の効果が認められるようになる。As mentioned above, the single administration of the sugar alcohol according to the present invention has a remarkable effect of improving constipation.
そして、このような効果は、ヒト小腸微絨毛に存在する
β−ガうクトシダーゼが大きいため、本発明による糖ア
ルコールは小腸で分解されずに大腸まで到達し、その結
果、大腸内の浸透圧が高くなって糞便を軟化して便秘を
改善するものと推定される。This effect is due to the large amount of β-gauctosidase present in human small intestinal microvilli, so the sugar alcohol of the present invention reaches the large intestine without being decomposed in the small intestine, and as a result, the osmotic pressure in the large intestine increases. It is presumed that this increases in concentration and softens feces to improve constipation.
光曵夏泣果
以上述べたとおり、本発明に係る糖アルコールは、ビフ
ィズス菌に対して優れた増殖促進効果を示し、さらに、
便秘改善効果についても排便回数の増加及び糞便の軟化
をもたらすという優れた効果を示す。As mentioned above, the sugar alcohol according to the present invention exhibits an excellent growth-promoting effect on Bifidobacterium, and furthermore,
It also shows excellent constipation-improving effects, increasing the frequency of defecation and softening feces.
以下実施例を示して本発明を具体的に説明する。The present invention will be specifically described below with reference to Examples.
実施例1
糖アルコールの調製:
10kgの乳糖(市販品)を15kgの温水に溶解した
?8液にクエン酸を加えてpHを4.5に調整したもの
に、β−ガラクトシダーゼ5万単位を加えて、40°C
で10時間反応させた。得られた反応混液を105°C
で2秒間加熱して酵素を失活させた。Example 1 Preparation of sugar alcohol: 10 kg of lactose (commercially available) was dissolved in 15 kg of warm water. Add citric acid to the 8 solution to adjust the pH to 4.5, add 50,000 units of β-galactosidase, and heat at 40°C.
The mixture was allowed to react for 10 hours. The resulting reaction mixture was heated to 105°C.
The enzyme was inactivated by heating for 2 seconds.
次に、この液2kgを活性炭−セライト(2:1)カラ
ム(φ50cm X 50c11)に通じて、乳糖と転
移ガラクトオリゴ糖の一部を吸着さ一部た。次いで、1
5kgの水をカラムに通じて単糖と未吸着の乳糖を溶出
し、除去後、5%エタノール20kgをカラムに通して
吸着した乳糖を完全に溶出し、除去した。次に、40%
のエタノール10kgをカラムに通じて得られた溶出液
を減圧濃縮後、凍結乾燥してガラクトオリゴtJ!95
重量%以上を含む粉末150gを得た。Next, 2 kg of this liquid was passed through an activated carbon-Celite (2:1) column (φ50 cm x 50 c11) to adsorb some of the lactose and transferred galacto-oligosaccharides. Then 1
5 kg of water was passed through the column to elute and remove monosaccharides and unadsorbed lactose, and then 20 kg of 5% ethanol was passed through the column to completely elute and remove the adsorbed lactose. Next, 40%
The eluate obtained by passing 10 kg of ethanol through the column was concentrated under reduced pressure and then lyophilized to obtain galacto-oligo tJ! 95
150 g of powder containing more than % by weight was obtained.
次に、水素化ホウ素ナトリウム水溶液(10%W/V)
3eに上記方法により得られたガラクトオリゴ糖粉末1
50gを溶解し、室温にて3時間還元反応を行った。反
応終了後、酢酸を用いてpH7,0になるまで中和した
。これにより反応液中に過剰に存在する未反応水素化ホ
ウ素ナトリウムを分解し得る。Next, sodium borohydride aqueous solution (10% W/V)
Galactooligosaccharide powder 1 obtained by the above method in 3e
50 g was dissolved and a reduction reaction was performed at room temperature for 3 hours. After the reaction was completed, the mixture was neutralized using acetic acid until the pH reached 7.0. This makes it possible to decompose unreacted sodium borohydride present in excess in the reaction solution.
次に、このものを減圧留去し31のメタノールに再度!
l!濁し、再び減圧留去した。この操作を2回繰り返し
た後、水11に溶解したl夜を脱塩樹脂に通液し脱塩を
行った。得られた溶液を減圧a縮径、凍結乾燥すること
により、前記式(1)、(2)及び(3)で表わされる
糖アルコールを含む糖アルコール粉末150gを得た。Next, this material was distilled off under reduced pressure and added to methanol in step 31 again!
l! It became cloudy and was distilled off again under reduced pressure. After repeating this operation twice, the solution dissolved in water 11 was passed through a desalting resin to perform desalting. The resulting solution was reduced in size under reduced pressure and freeze-dried to obtain 150 g of sugar alcohol powder containing the sugar alcohols represented by formulas (1), (2), and (3).
実施例2
実施例1に記載したと同様の手順に従ってガラクトオリ
ゴ糖95重量%以上を含む粉末150gを得、次いで該
粉末を濃度50%(n/v)に溶解し、これにラネーニ
ッケル1[L%を添加し、撹拌しながら温度を90−1
25°Cに昇温し、水素圧を20〜100kg/cJに
あげて水素化を完了させた後、ラネーニッケルを除去し
、常法に従って活性炭、イオン交換樹脂を用い、精製し
たものを減圧濃縮し、更に凍結乾燥して前記式(1)、
(2)及び(3)で表わされる糖アルコルを含む糖アル
コール粉末150gを得た。Example 2 150 g of a powder containing at least 95% by weight of galacto-oligosaccharides was obtained according to the same procedure as described in Example 1, the powder was then dissolved to a concentration of 50% (n/v), and Raney nickel 1 [L% and increase the temperature to 90-1 while stirring.
After raising the temperature to 25°C and raising the hydrogen pressure to 20 to 100 kg/cJ to complete hydrogenation, Raney nickel was removed, and the purified product was concentrated under reduced pressure using activated carbon and ion exchange resin according to a conventional method. , further freeze-dried to obtain the formula (1),
150 g of sugar alcohol powder containing sugar alcohols represented by (2) and (3) was obtained.
実施例3
10kgのラクチトールを15kgの温水に溶解した溶
液にクエン酸を加えpH4,5に調整したものに、β−
ガラクトシダーゼ53単位を加え、40°Cで10時間
反応させた。Example 3 β-
53 units of galactosidase were added and reacted at 40°C for 10 hours.
得られた反応混液を105°Cで2秒間加熱して酵素を
失活させた。The resulting reaction mixture was heated at 105°C for 2 seconds to inactivate the enzyme.
次に、この液2kgを活性炭−セライト(2: 1)カ
ラム(φ50cm X 50c+w)に通してラクチト
ールと転移糖アルコールを吸着させた0次いで、1.5
k gの水をカラムに通し、単糖とソルビトール未吸
着のラクチトールを溶出し除去後、5%エタノール20
kgをカラムに通し吸着したラクチトールを完全に溶出
し、除去した。次に、40%エタノール10kgをカラ
ムに通し得られた溶出液を減圧1縮後、凍結乾燥して前
記式(1)、(2)、及び(3)で表わされる糖アルコ
ールを含む粉末150gを得た。Next, 2 kg of this liquid was passed through an activated carbon-Celite (2:1) column (φ50 cm x 50 c+w) to adsorb lactitol and transferred sugar alcohol.
Kg of water was passed through the column to elute and remove monosaccharides and unadsorbed lactitol, and then 5% ethanol 20
kg was passed through the column to completely elute and remove the adsorbed lactitol. Next, the eluate obtained by passing 10 kg of 40% ethanol through the column was concentrated once under reduced pressure, and then lyophilized to obtain 150 g of powder containing sugar alcohols represented by the above formulas (1), (2), and (3). Obtained.
添付図は、本発明による糖アルコールのビフィズス菌に
対する増殖促進効果を、乳糖との対比で示したものであ
る。The attached figure shows the growth promoting effect of the sugar alcohol of the present invention on bifidobacteria in comparison with lactose.
Claims (10)
ソルビトール残基をそれぞれ示し、nは1〜4の整数を
示す)で表わされる糖アルコール。(1) General formula (I) Gal-(Gal)_nSor(I) (wherein, Gal represents a galactose residue, Sor represents a sorbitol residue, and n represents an integer from 1 to 4). sugar alcohol.
−D−ガラクトピラノシル−(1→4)−D−ソルビト
ールで表わされる請求項(1)に記載の糖アルコール。(2) Formula O-β-D-galactopyranosyl-(1→6)-O-β
The sugar alcohol according to claim (1), which is represented by -D-galactopyranosyl-(1→4)-D-sorbitol.
−D−ガラクトピラノシル−(1→4)−D−ソルビト
ールで表わされる請求項(1)に記載の糖アルコール。(3) Formula O-β-D-galactopyranosyl-(1→3)-O-β
The sugar alcohol according to claim (1), which is represented by -D-galactopyranosyl-(1→4)-D-sorbitol.
β−D−ガラクトピラノシル−(1→6)〕−D−ソル
ビトールで表わされる請求項(1)に記載の糖アルコー
ル。(4) Formula O-β-D-galactopyranosyl-(1→4)-[O-
The sugar alcohol according to claim 1, which is represented by β-D-galactopyranosyl-(1→6)]-D-sorbitol.
はβ−グルコシダーゼを作用させて乳糖分子中のガラク
トース残基に転移反応を行わせることによりオリゴ糖を
生成し、次いで得られたオリゴ糖のグルコース残基を還
元することを特徴とする糖アルコールの製造方法。(5) Oligosaccharides are produced by allowing β-galactosidase or β-glucosidase to act on lactose or lactose-containing substances to perform a transfer reaction on galactose residues in lactose molecules, and then the glucose residues of the obtained oligosaccharides are A method for producing a sugar alcohol, characterized by reducing a group.
くはエタノール溶液中で水素化ホウ素ナトリウムと反応
させることにより行う請求項(5)に記載の糖アルコー
ルの製造方法。(6) The method for producing a sugar alcohol according to claim (5), wherein the reduction of the glucose residue of the oligosaccharide is carried out by reacting with sodium borohydride in an aqueous solution or an ethanol solution.
媒を用い高温高圧下において水素と反応させることによ
り行う請求項(5)に記載の糖アルコールの製造方法。(7) The method for producing a sugar alcohol according to claim (5), wherein the reduction of the glucose residue of the oligosaccharide is carried out by reacting with hydrogen at high temperature and high pressure using a nickel catalyst.
クトシダーゼ或はβ−グルコシダーゼを作用させてラク
チトール分子中のガラクトース残基に転移反応を行わせ
ることを特徴とする糖アルコールの製造方法。(8) A method for producing a sugar alcohol, which comprises allowing β-galactosidase or β-glucosidase to act on lactitol or a lactitol-containing substance to cause a transfer reaction to galactose residues in lactitol molecules.
ソルビトール残基をそれぞれ示し、nは1〜4の整数を
示す)で表わされる糖アルコールを活性成分として含有
するビフィドバクテリウム菌の増殖促進組成物。(9) General formula (I) Gal-(Gal)_n-Sor(I) (However, in the formula, Gal represents a galactose residue, Sor represents a sorbitol residue, and n represents an integer from 1 to 4) A composition for promoting the growth of Bifidobacterium, which contains a sugar alcohol represented by the following as an active ingredient.
ソルビトール残基をそれぞれ示す)で表わされる糖アル
コールを活性成分として含有する便秘改善性組成物。(10) Contains a sugar alcohol represented by the general formula (I) Gal-(Gal)_n-Sor(I) (in the formula, Gal represents a galactose residue and Sor represents a sorbitol residue, respectively) as an active ingredient. A constipation-improving composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1-50749 | 1989-03-02 | ||
JP5074989 | 1989-03-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0341085A true JPH0341085A (en) | 1991-02-21 |
JP2796634B2 JP2796634B2 (en) | 1998-09-10 |
Family
ID=12867486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1191296A Expired - Fee Related JP2796634B2 (en) | 1989-03-02 | 1989-07-26 | Novel sugar alcohol, production method thereof and use thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2796634B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011036203A (en) * | 2009-08-14 | 2011-02-24 | Yakult Honsha Co Ltd | Probiotics proliferation promoter |
-
1989
- 1989-07-26 JP JP1191296A patent/JP2796634B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011036203A (en) * | 2009-08-14 | 2011-02-24 | Yakult Honsha Co Ltd | Probiotics proliferation promoter |
Also Published As
Publication number | Publication date |
---|---|
JP2796634B2 (en) | 1998-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hidaka et al. | Fructooligosaccharides enzymatic preparation and biofunctions | |
JP3403496B2 (en) | Anti-ulcer agent and Helicobacter pylori colonization inhibitor | |
JPS62201901A (en) | Beta-d-glucan and its production and use | |
JP2002528063A (en) | sweetener | |
JP2023073244A (en) | Intestinal environment improvement composition and method for manufacturing the same | |
JP2019043867A (en) | Composition for promoting increase of Akkermansia muciniphila | |
JP2750767B2 (en) | New sugar alcohol | |
JP2904687B2 (en) | New oligosaccharide | |
JP2731948B2 (en) | New oligosaccharides and their production and use | |
JPS6316118B2 (en) | ||
JPH0341085A (en) | Novel sugar alcohol, its production and use | |
JPS5820266B2 (en) | Bifidobacterium growth-promoting composition and method for producing the same | |
JPS5899497A (en) | Novel oligosaccharide, its preparation, and agent for accelerating proliferation of bacterium belonging to bifidobacterium genus | |
JPS58212780A (en) | Growth promoting substance for microorganism of genus bifidobacterium | |
JP4637976B2 (en) | Intestinal metabolism improving agent | |
JPH08301772A (en) | Antiviral agent containing sulfated polysaccharide calcium salt | |
JPH06228181A (en) | New oligosaccharide comprising glucuronic acid, its production and utilization | |
JPH0131487B2 (en) | ||
JP3572103B2 (en) | Secondary bile acid lowering agent | |
JP2020200288A (en) | Agent for preventing or improving osteoarthritis | |
WO2011043435A1 (en) | Therapeutic agent for influenza virus infectious diseases | |
JP4049278B2 (en) | Intestinal metabolism improving agent | |
JP6629021B2 (en) | Immunoglobulin A secretagogue | |
JPS5911190A (en) | Novel oligosaccharide, its preparation, propagation promotor for bifidobacterium comprising oligosaccharide as active ingredient | |
JP4500008B2 (en) | Novel disaccharide, composition containing the same, and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |